Meyers Lindsay, Ginocchio Christine C, Faucett Aimie N, Nolte Frederick S, Gesteland Per H, Leber Amy, Janowiak Diane, Donovan Virginia, Dien Bard Jennifer, Spitzer Silvia, Stellrecht Kathleen A, Salimnia Hossein, Selvarangan Rangaraj, Juretschko Stefan, Daly Judy A, Wallentine Jeremy C, Lindsey Kristy, Moore Franklin, Reed Sharon L, Aguero-Rosenfeld Maria, Fey Paul D, Storch Gregory A, Melnick Steve J, Robinson Christine C, Meredith Jennifer F, Cook Camille V, Nelson Robert K, Jones Jay D, Scarpino Samuel V, Althouse Benjamin M, Ririe Kirk M, Malin Bradley A, Poritz Mark A
BioFire Diagnostics, Salt Lake City, UT, United States.
bioMérieux USA, Durham, NC, United States.
JMIR Public Health Surveill. 2018 Jul 6;4(3):e59. doi: 10.2196/publichealth.9876.
Health care and public health professionals rely on accurate, real-time monitoring of infectious diseases for outbreak preparedness and response. Early detection of outbreaks is improved by systems that are comprehensive and specific with respect to the pathogen but are rapid in reporting the data. It has proven difficult to implement these requirements on a large scale while maintaining patient privacy.
The aim of this study was to demonstrate the automated export, aggregation, and analysis of infectious disease diagnostic test results from clinical laboratories across the United States in a manner that protects patient confidentiality. We hypothesized that such a system could aid in monitoring the seasonal occurrence of respiratory pathogens and may have advantages with regard to scope and ease of reporting compared with existing surveillance systems.
We describe a system, BioFire Syndromic Trends, for rapid disease reporting that is syndrome-based but pathogen-specific. Deidentified patient test results from the BioFire FilmArray multiplex molecular diagnostic system are sent directly to a cloud database. Summaries of these data are displayed in near real time on the Syndromic Trends public website. We studied this dataset for the prevalence, seasonality, and coinfections of the 20 respiratory pathogens detected in over 362,000 patient samples acquired as a standard-of-care testing over the last 4 years from 20 clinical laboratories in the United States.
The majority of pathogens show influenza-like seasonality, rhinovirus has fall and spring peaks, and adenovirus and the bacterial pathogens show constant detection over the year. The dataset can also be considered in an ecological framework; the viruses and bacteria detected by this test are parasites of a host (the human patient). Interestingly, the rate of pathogen codetections, on average 7.94% (28,741/362,101), matches predictions based on the relative abundance of organisms present.
Syndromic Trends preserves patient privacy by removing or obfuscating patient identifiers while still collecting much useful information about the bacterial and viral pathogens that they harbor. Test results are uploaded to the database within a few hours of completion compared with delays of up to 10 days for other diagnostic-based reporting systems. This work shows that the barriers to establishing epidemiology systems are no longer scientific and technical but rather administrative, involving questions of patient privacy and data ownership. We have demonstrated here that these barriers can be overcome. This first look at the resulting data stream suggests that Syndromic Trends will be able to provide high-resolution analysis of circulating respiratory pathogens and may aid in the detection of new outbreaks.
医疗保健和公共卫生专业人员依靠对传染病进行准确、实时的监测来做好疫情防范和应对工作。对于病原体全面且具有针对性但能快速报告数据的系统,有助于早期发现疫情。事实证明,在大规模实施这些要求的同时保护患者隐私是困难的。
本研究的目的是以保护患者隐私的方式,展示对美国各地临床实验室传染病诊断检测结果的自动导出、汇总和分析。我们假设这样一个系统有助于监测呼吸道病原体的季节性发生情况,并且与现有监测系统相比,在范围和报告便捷性方面可能具有优势。
我们描述了一个名为BioFire Syndromic Trends的系统,用于基于综合征但针对病原体的快速疾病报告。来自BioFire FilmArray多重分子诊断系统的去识别患者检测结果直接发送到云数据库。这些数据的汇总在Syndromic Trends公共网站上近乎实时显示。我们研究了这个数据集,以了解过去4年中从美国20个临床实验室获取的超过362,000份患者样本中检测到的20种呼吸道病原体的流行情况、季节性和合并感染情况。
大多数病原体呈现类似流感的季节性,鼻病毒在秋季和春季出现高峰,腺病毒和细菌性病原体全年均可检测到。该数据集也可以在生态框架中进行考虑;此检测所发现的病毒和细菌是宿主(人类患者)的寄生虫。有趣的是,病原体合并检测率平均为7.94%(28,741/362,101),与基于所存在生物体相对丰度的预测相符。
Syndromic Trends通过去除或模糊患者标识符来保护患者隐私,同时仍收集有关患者携带的细菌和病毒病原体的许多有用信息。检测结果在完成后几小时内上传到数据库,而其他基于诊断的报告系统则会延迟长达10天。这项工作表明,建立流行病学系统的障碍不再是科学和技术方面的,而是行政方面的,涉及患者隐私和数据所有权问题。我们在此证明了这些障碍是可以克服的。对所得数据流的初步观察表明,Syndromic Trends将能够对传播的呼吸道病原体进行高分辨率分析,并可能有助于发现新的疫情。